Skip to main content


Log in

Utility of measuring C-reactive protein for prediction of in-hospital events in patients with acute aortic dissection

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript


Controlling blood pressure is essential for prevention of events after acute aortic dissection (AAD). However, in some instances a cardiac event occurs despite controlled blood pressure, and its prediction is difficult. We continuously monitored C-reactive protein (CRP) in patients receiving medical treatment for AAD and retrospectively examined the utility of CRP measurement for prediction of in-hospital events. Five hundred and eight patients were diagnosed as having AAD between 1993 and 2009, 240 of whom underwent antihypertensive medical therapy. These subjects were 156 males and 84 females, average age 67.4 years, with 68 cases of Stanford type A and 172 cases of Stanford type B. C-reactive protein was measured in all patients daily until a peak; subsequently, CRP was measured 2–3 times per week following the peak until discharge. In the event-free group CRP demonstrated a peak on the 4th day after the onset (average 13.7 mg/dl), then gradually decreased to an average of 4.6 mg/dl 4 weeks later, displaying a “gradual decay” pattern. Despite controlled systolic arterial pressure of approximately 120 mmHg, 7 of 68 Stanford A cases (10.3 %) and 8 of 172 Stanford B cases (4.7 %) developed cardiovascular events. The group characterized by events exhibited a CRP pattern distinct from that of the event-free group, i.e., prolonged elevation and/or re-elevation. We demonstrated that the CRP pattern could provide information regarding prediction of cardiovascular events. Prolonged elevation or re-elevation of CRP may indicate the necessity of (1) application of computed tomography or magnetic resonance imaging, (2) more rigorous blood pressure management, or (3) early surgical intervention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others


  1. Crawford ES (1990) The diagnosis and management of aortic dissection. JAMA 264:2537–2541

    Article  PubMed  CAS  Google Scholar 

  2. Harris KM, Strauss CE, Eagle KA, Hirsch AT, Isselbacher EM, Tsai TT, Shiran H, Fattori R, Evangelista A, Cooper JV, Montgomery DG, Froehlich JB, Nienaber CA, International Registry of Acute Aortic Dissection (IRAD) Investigators (2011) Correlates of delayed recognition and treatment of acute type A aortic dissection: the International Registry of Acute Aortic Dissection (IRAD). Circulation 124:1911–1918

    Article  PubMed  Google Scholar 

  3. Trimarchi S, Eagle KA, Nienaber CA, Rampoldi V, Jonker FH, De Vincentiis C, Frigiola A, Menicanti L, Tsai T, Froehlich J, Evangelista A, Montgomery D, Bossone E, Cooper JV, Li J, Deeb MG, Meinhardt G, Sundt TM, Isselbacher EM, International Registry of Acute Aortic Dissection Investigators (2010) Role of age in acute type A aortic dissection outcome: report from the International Registry of Acute Aortic Dissection (IRAD). J Thorac Cardiovasc Surg 140:784–789

    Article  PubMed  Google Scholar 

  4. Booher AM, Isselbacher EM, Nienaber CA, Froehlich JB, Trimarchi S, Cooper JV, Demertzis S, Ramanath VS, Januzzi JL, Harris KM, O’Gata PT, Sundt TM, Pyeritz RE, Eagle KA, International Registry of Acute Aortic Dissection (IRAD) Investigators (2011) Ascending thoracic aorta dimension and outcomes in acute type B dissection (from the IRAD). Am J Cardiol 107:315–320

    Article  PubMed  Google Scholar 

  5. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE, Eagle KA, Hermann LK, Isselbacher EM, Kazerooni EA, Kouchoukos NT, Lytle BW, Milewicz DM, Reich DL, Sen S, Shinn JA, Sevensson LG, Williams DM (2010) 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease. Circulation 121:e266–e369

    Article  PubMed  Google Scholar 

  6. Tsai TT, Evangelista A, Nienaber CA, Myrmel T, Meinhardt G, Cooper JV, Smith DE, Suzuki T, Fattori R, Llovet A, Froehlich J, Hutchison S, Distante A, Sundt T, Beckman J, Januzzi JL, Isselbacher EM, Eagle KA (2007) Partial thrombosis of the false lumen in patients with acute type B aortic dissection. N Engl J Med 357:349–359

    Article  PubMed  CAS  Google Scholar 

  7. Trimarchi S, Eagle KA, Nienaber CA, Pyeritz RE, Jonker FH, Suzuki T, O’Gara PT, Hutchinson SJ, Rampoldi V, Grassi V, Bossone E, Muhs BE, Evangelista A, Tsai TT, Froehlich JB, Cooper JV, Montgomery D, Meinhardt G, Myrmel T, Upchurch GR, Sundt TM, Isselbacher EM, International Registry of Acute Aortic Dissection (IRAD) Investigators (2010) Importance of refractory pain and hypertension in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation 122:1283–1289

    Article  PubMed  Google Scholar 

  8. Baikoussis NG, Apostolakis EE, Siminelakis SN, Papadopoulos GS, Goudevenos J (2009) Intramural haematoma of the thoracic aorta: who’s to be alerted the cardiologist or the cardiac surgeon? J Cardiothorac Surg 4:54. doi:10.1186/1749-8090-4-54

    Article  PubMed  Google Scholar 

  9. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JP, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ, For the JUPITER Study Group (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359:2195–2207

    Article  PubMed  CAS  Google Scholar 

  10. Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, Engstrom G, Persson M, Smith JG, Magnusson M, Christensson A, Struck J, Morgenthaler N, Bergmann A, Pencina M, Wang TJ (2009) Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 302:49–57

    Article  PubMed  CAS  Google Scholar 

  11. Weng CW, Chou CH, Huang YY, Lin CC, Liu YW, Tsai WC (2010) Increased C-reactive protein is associated with future development of diabetes mellitus in essential hypertension patients. Heart Vessels 25:386–391

    Article  PubMed  Google Scholar 

  12. Quarck R, Nawrot T, Meyns B, Delcroix M (2009) C-reactive protein. A new predictor of adverse outcome in pulmonary arterial hypertension. J Am Coll Cardiol 53:1211–1218

    Article  PubMed  CAS  Google Scholar 

  13. Ranasinghe AM, Bonser RS (2010) Biomarkers in acute aortic dissection and other aortic syndrome. J Am Coll Cardiol 56:1535–1541

    Article  PubMed  CAS  Google Scholar 

  14. Jo Y, Anzai T, Ueno K, Kaneko H, Kohno T, Sugano Y, Maekawa Y, Yoshikawa T, Shimizu H, Yozu R, Ogawa S (2010) Re-elevation of D-dimer as a predictor of re-dissection and venous thromboembolism after Stanford type B acute aortic dissection. Heart Vessels 25:509–514

    Article  PubMed  Google Scholar 

  15. Braverman AC (2010) Acute aortic dissection: clinician update. Circulation 122:184–188

    Article  PubMed  Google Scholar 

  16. Jo Y, Anzai T, Sugano Y, Naito K, Ueno K, Kohno T, Yoshikawa T, Ogawa S (2008) Early use of beta-blockers attenuates systemic inflammatory response and lung oxygenation impairment after distal type acute aortic dissection. Heart Vessels 23:334–340

    Article  PubMed  Google Scholar 

  17. Girdauskas E, Kuntze T, Borger MA, Falk V, Mohr FW (2009) Surgical risk of preoperative malperfusion in acute type A aortic dissection. J Thorac Cardiovasc Surg 138:1363–1369

    Article  PubMed  Google Scholar 

  18. Suzuki T, Isselbacher EM, Nienaber CA, Pyeritz RE, Eagle KA, Tsai TT, Cooper JV, Januzzi JL, Braverman AC, Montgomery DG, Fattori R, Pape L, Harris KM, Booher A, Oh JK, Peterson M, Ramanath VS, Froehlich JB (2012) Type-selective benefits of medications in treatment of acute aortic dissection (from the International Registry of Acute Aortic Dissection [IRAD]). Am J Cardiol 109:122–127

    Article  PubMed  CAS  Google Scholar 

  19. Schillinger M, Domanovits H, Bayegan K, Holzenbein T, Grabenwoger M, Thoenissen J, Roggla M, Mullner M (2002) C-reactive protein and mortality in patients with acute aortic disease. Intensive Care Med 28:740–750

    Article  PubMed  Google Scholar 

  20. Sakakura K, Kubo N, Ako J, Wada H, Fujiwara N, Funayama H, Ikeda N, Nakamura T, Sugawara Y, Yasu T, Kawakami M, Momomura S (2010) Peak C-reactive protein level predicts long-term outcomes in type B acute aortic dissection. Hypertension 55:422–429

    Article  PubMed  CAS  Google Scholar 

  21. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K (2003) Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives. Circulation 107:1401–1406

    Article  PubMed  Google Scholar 

  22. Ueda T, Kai H, Imaizumi T (2012) Losartan/hydrochlorothiazide combination vs. high-dose losartan in patients with morning hypertension—a prospective, randomized, open-labeled, parallel-group, multicenter trial. Hypertens Res. doi:10.1038/hr.2012.27

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Masanao Ohuchida.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Okina, N., Ohuchida, M., Takeuchi, T. et al. Utility of measuring C-reactive protein for prediction of in-hospital events in patients with acute aortic dissection. Heart Vessels 28, 330–335 (2013).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: